title: Screening the MayBridge Rule of 3 Fragment Library for Compounds That Interact with the Trypanosoma brucei myo-Inositol-3-Phosphate Synthase and/or Show Trypanocidal Activity.
abstract: Inositol-3-phosphate synthase (INO1) has previously been genetically validated as a drug target against Trypanosoma brucei, the causative agent of African sleeping sickness. Chemical intervention of this essential enzyme could lead to new therapeutic agents. Unfortunately, no potent inhibitors of INO1 from any organism have been reported, so a screen for potential novel inhibitors of T. brucei INO1was undertaken. Detection of inhibition of T. brucei INO1 is problematic due to the nature of the reaction. Direct detection requires differentiation between glucose-6-phosphate and inositol-3-phosphate. Coupled enzyme assays could give false positives as potentially they could inhibit the coupling enzyme. Thus, an alternative approach of differential scanning fluorimetry to identify compounds that interact with T. brucei INO1 was employed to screen ~670 compounds from the MayBridge Rule of 3 Fragment Library. This approach identified 38 compounds, which significantly altered the T(m) of TbINO1. Four compounds showed trypanocidal activity with ED50s in the tens of micromolar range, with 2 having a selectivity index in excess of 250. The trypanocidal and general cytotoxicity activities of all of the compounds in the library are also reported, with the best having ED50S of ~20 μM against T. brucei.
authors.affiliation: Biomolecular Science, The North Haugh, The University of St. Andrews, Fife, Scotland, KY16 9ST, UK.
authors.forename: Louise L
authors.initials: LL
authors.lastname: Major
authors.forename: Terry K
authors.initials: TK
authors.lastname: Smith
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10336-41
references.pmid: 10954751
references.citation: Mol Microbiol. 2004 Feb;51(4):1003-14
references.pmid: 14763976
references.citation: Cytotechnology. 1998 May;26(3):173-83
references.pmid: 22358615
references.citation: Mol Microbiol. 2006 Jul;61(1):89-105
references.pmid: 16824097
references.citation: EMBO J. 2004 Nov 24;23(23):4701-8
references.pmid: 15526036
references.citation: Biochem J. 2006 Jun 1;396(2):287-95
references.pmid: 16475982
references.citation: Mol Biochem Parasitol. 2002 Mar;120(1):151-6
references.pmid: 11849714
references.citation: J Biol Chem. 1986 Jan 5;261(1):356-62
references.pmid: 2934386
references.citation: J Biol Chem. 1985 Nov 25;260(27):14547-55
references.pmid: 4055788
references.citation: Anal Biochem. 2004 Sep 1;332(1):153-9
references.pmid: 15301960
references.citation: Parasitol Int. 2000 Jan;48(3):265-9
references.pmid: 11227767
references.citation: Mol Microbiol. 2005 Sep;57(6):1608-22
references.pmid: 16135228
references.citation: J Bacteriol. 1977 Apr;130(1):472-84
references.pmid: 323239
references.citation: Biochem J. 1945;39(4):285-7
references.pmid: 16747905
references.citation: J Biol Chem. 1984 Mar 10;259(5):3011-5
references.pmid: 6699005
references.citation: Nat Protoc. 2007;2(9):2212-21
references.pmid: 17853878
references.citation: Biochem Soc Trans. 2005 Nov;33(Pt 5):983-5
references.pmid: 16246027
references.citation: J Biol Chem. 2004 Apr 2;279(14):13889-95
references.pmid: 14684747
references.citation: Carcinogenesis. 1980 Jun;1(6):495-9
references.pmid: 7273282
references.citation: Biochim Biophys Acta. 1999 Oct 8;1455(2-3):327-40
references.pmid: 10571022
references.citation: Bioessays. 1996 Apr;18(4):283-91
references.pmid: 8967896
references.citation: Drug Discov Today. 2005 Jul 15;10(14):987-92
references.pmid: 16023057
references.citation: J Biol Chem. 2005 Mar 25;280(12):11475-82
references.pmid: 15653679
references.citation: J Biol Chem. 2002 Dec 20;277(51):50176-82
references.pmid: 12364327
references.citation: Molecules. 2007 Aug 07;12(8):1720-30
references.pmid: 17960083
references.citation: Biochemistry. 2005 Jan 11;44(1):213-24
references.pmid: 15628862